Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of AFP Specific T Cell Receptor Transduced T Cells Injection in Unresectable Hepatocellular Carcinoma

NCT04368182 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT04368182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04368182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of AFP Specific T Cell Receptor Transduced T Cells Injection in Unresectable Hepatocellular Carcinoma
Lead sponsor
Zhejiang University
Phase
Phase 1
Overall status
Unknown status
Start date
April 13, 2020
Completion date
November 30, 2021
Enrollment
3 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma